Your provider may be able to switch to alternatives with a more neutral metabolic profile
SURMOUNT-1 demonstrated 15%, 19.5%, and 20.9% body weight reduction at 5, 10, and 15 mg respectively over 72 weeks FDA approvals : Mounjaro (T2D, May 2022) and Zepbound (obesity, November 2023) Cardiovascular outcomes : SURPASS-CVOT in progress to evaluate cardiovascular safety and efficacy Global availability : Approved in US, EU, and numerous international markets Side Effects and Safety Comparison# Mazdutide Side Effects# GI effects : Nausea, diarrhea, and vomiting consistent with GLP-1 class
Busy work schedules, high stress levels, lack of sleep, and processed food availability all contribute to environmentally reinforced obesity
Clinical trial data from the SUSTAIN and STEP programs indicate that nausea, the most frequently reported side effect, generally improves within 46 weeks for most patients as tolerance develops
LIPOSOMAL COLLAGEN COMPLEX+ Vitamin C Lipo-Sachets Liposomal vitamin C delivering 80% higher absorption than standard vitamin C